Treatment of Post-partum Depression Using an Behavioral Intervention Called ROSE (Reach Out, Stay Strong, Essentials for Mothers of Newborns) Delivered Using an Electronic App
Post-partum Depression
About this trial
This is an interventional treatment trial for Post-partum Depression
Eligibility Criteria
Inclusion Criteria:
- 20-35 weeks pregnant
- enrolled for prenatal care in one of the five identified practices
- English speaking
- have one or more of the following PPD risk factors: Medicaid eligible; anxiety (GAD-7 > 10) during pregnancy; mild to moderate depressive symptoms (PHQ-9 = 10-19); self-reported history of depression treatment; gestational diabetes; and/or young age (18-21 years).
Exclusion Criteria:
- patients with acute mental health needs
- cannot communicate in English
- demonstrate significant cognitive impairment
- are planning to place the child for adoption
- PHQ-9 depression score > 19
- younger than age 18
Sites / Locations
- University of Rochester Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Active Comparator
No Intervention
No Intervention
women receiving InBloom app
women receiving ROSE as usual
historical controls- no treatment
electronic health record utilization data
We will capitalize on data from a large ROSE trial which consists of a demographically similar sample by comparing depression diagnosis outcomes for Inbloom and ROSE to the 96 participants in the care as usual group (an educational pamphlet on PPD).
We will leverage EHR utilization data by retrospectively identifying 152 people from the same clinics who did not receive ROSE or InBloom and matched for eligibility criteria, demographics and PPD risk factors using propensity scores, and comparing their utilization to those in the ROSE and InBloom groups.